Summary:Waters Corporation (NYSE:WAT) today introduced a new peptide multi-attribute method (MAM) workflow f
Waters Corporation (NYSE:WAT) today introduced a new peptide multi-attribute method (MAM) workflow for the Waters™ BioAccord™ LC-MS System,
enabling drug development, manufacturing, and QC scientists